Research and Markets (http://www.researchandmarkets.com/research/f94wnk/relapsing)
has announced the addition of the "Relapsing
Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2014"
report to their offering.
Our clinical trial report, Relapsing Multiple Sclerosis (RMS) Global
Clinical Trials Review, H2, 2014" provides data on the Relapsing
Multiple Sclerosis (RMS) clinical trial scenario. This report provides
elemental information and data relating to the clinical trials on
Relapsing Multiple Sclerosis (RMS). It includes an overview of the trial
numbers and their recruitment status as per the site of trial cnduction
across the globe.
The databook offers a preliminary coverage of disease clinical trials by
their phase, trial status, prominence of the sponsors and also provides
briefing pertaining to the number of trials for the key drugs for
treating Relapsing Multiple Sclerosis (RMS). This report is built using
data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by Our team of industry experts.
Reasons to buy
For more information visit http://www.researchandmarkets.com/research/f94wnk/relapsing
[ Back To NFVZone's Homepage ]